# Tempus AI Launches OneOme Pharmacogenomics Solution Nationally

> partnership · REPORTED · 2026-07-22

Tempus AI announced the national launch of its OneOme pharmacogenomics testing solution on July 22, 2026, delivering genetic insights to guide drug selection and dosing decisions for patients at scale across its existing clinical network.

About Tempus AI: Tempus AI is a technology company that applies artificial intelligence and genomics to precision medicine, serving oncologists and other clinicians with sequencing diagnostics, AI analytics, and now pharmacogenomic testing.

- Company: Tempus AI
- Sector: diagnostics
- Primary source: https://investors.tempus.com/news-events/news-releases

---
Source: MedFuel Intel news monitor. Verification tier: REPORTED. Informational only, not investment advice. Corrections: media@medfuelinc.com.